Business News

Aragen Life Sciences files draft papers with Sebi to raise funds through IPO

FinSiddhi

Aragen Life Sciences has filed its DRHP with Sebi for an IPO comprising a Rs 800 crore fresh issue and an OFS. Proceeds will fund debt repayment, capacity expansion and equipment purchases. The CRDMO reported strong FY24–FY26 growth, with revenue reaching Rs 2,178 crore and profit Rs 258 crore in FY26.
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.

Related Posts

Are IT cos simply raising capacity or adding value?

But the trend has also revived an old debate: are these deals about acquiring capabilities or simply adding to their capacity? The strategy is driven partly by the need to grow contract values as organic revenue expansion slows for Indian IT companies and artificial intelligence reshapes traditional technology spending. The strategy is not entirely new.